Women’s Protection in Telehealth Act
Latest action: Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. · Feb 13, 2025
View full text on Congress.gov ↗ Policy area: Health
Women’s Protection in Telehealth Act This bill excludes providers of abortion-inducing drugs from participating in Medicare unless the provider is a physician who physically examines the patient, is physically present when the drug is administered, and schedules an in-person follow-up visit with the patient within 14 days of administering the drug.
Source: Congressional Research Service (CRS).
Track HR 1349 in BallotBox360
Get real-time bill updates, floor vote alerts, and AI-powered summaries — all in one app.
Download on iOS Open Web App